Expression of hypoxia-related tissue factors correlates with diminished survival of adiuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications

Clinical Cancer Research

Volumn 10, Issue 19, 2004, Pages 6567-6571

  Birner, Peter ^a,b   Preusser, Matthias ^a   Gelpi, Ellen ^a   Berger, Johannes ^b   Gatterbauer, Brigitte ^b   Ambros, Inge M ^c   Ambros, Peter F ^c   Acker, Till ^d   Plate, Karl H ^d   Harris, Adrian L ^e   Hainfellner, Johannes A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c St Anna   (Austria)

^d GOETHE UNIVERSITY   (Germany)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC MARKER; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION;

ADULT; BRAIN NEOPLASMS; CARBONIC ANHYDRASES; CHEMOTHERAPY, ADJUVANT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; OLIGODENDROGLIOMA; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 5144231914     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0617     Document Type: Article

References (20)

1. Kleihues P, Cavenee W, editors. World Health Organisation classification of tumours: pathology and genetics of tumours of the nervous system. 1st ed. Lyon: IARC Press; 2000.
2. Bello MJ, Vaquero J, de Campos, et al. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994;57:172-5.
3. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst (Bethesda) 1998; 90:1473-9.
4. Jenkins RB, Curran W, Scott CB, Cairncross G. Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group. Am J Clin Oncol 2001;24: 506-8.
5. Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 2003;9:2234-40.
6. Sannazzari GL, Ricardi U, Filippi AR. Hypoxia and tumor response to irradiation. Rays 2002;27:175-9.
7. Gelpi E, Ambros IM, Birner P, et al. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens. Mod Pathol 2003;16:708-15.
8. Birner P, Gatterbauer B, Oberhuber G, et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer (Phila) 2001;92:165-71.
9. Bredel M, Gatterbauer B, Birner P, et al. Expression of DNA topoisomerase IIalpha in oligodendroglioma. Anticancer Res 2002;22: 1301-4.
10. Birner P, Piribauer M, Fischer I, et al. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol 2003;13:133-43.
11. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. DEC1 (STRA13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol 2003;200:222-8.
12. Breitschopf H, Suchanek G, Gould RM, Colman DR, Lassmann H. In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol 1992;84:581-7.
13. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond) 1992;359:845-8.
14. Bauman GS, Ino Y, Ueki K, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000;48:825-30.
15. Collingridge DR, Piepmeier JM, Rockwell S, Knisely JP. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 1999;53:127-31.
16. Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y. Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 1991;74:55-9.
17. Rampling R, Cruickshank G, Lewis AD, Fitzsimmons SA, Workman P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 1994;29:427-31.
18. van der Sanden BP, Heerschap A, Simonetti AW, et al. Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry. Int J Radiat Oncol Biol Phys 1999;44:649-58.
19. Robinson SP, Collingridge DR, Howe FA, et al. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12:98-106.
20. Beppu T, Kamada K, Yoshida Y, et al. Change of oxygen pressure in glioblastoma tissue under various conditions. J Neuro-Oncol 2002; 58:47-52.